-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Amphastar Pharma, Lowers Price Target to $23

Benzinga·04/08/2026 14:42:39
Listen to the news
Barclays analyst Glen Santangelo maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and lowers the price target from $30 to $23.